Neurology

The FDA has approved the first biosimilar treatment for patients living with relapsing forms of multiple sclerosis.

A new expert consensus was released by the American Academy of Neurology reviewing the currently available evidence on the efficacy and safety of antiamyloid monoclonal antibodies for the treatment of...

Researchers found that patients taking suvorexant had reduced levels of amyloid beta and tau phosphorylation, proteins that play a major role in neurodegeneration in Alzheimer disease.

A team of researchers sought to associate a link between symptoms of insomnia and the incidence of stroke in adults.

Can a dietary intervention known for reducing cardiovascular risk factors prevent cognitive decline in healthy older individuals? A team of researchers explored this question in a recent study.

This COVID-19 roundup includes a summary of studies on the effective treatment options for patients with long COVID, the risk of patients developing medical or mental health conditions post-hospitalization...

A team of researchers determined the impact of obstructive sleep apnea and insomnia on cognitive decline in women with multiple sclerosis.

Researchers investigated the association and the potential sex differences between hypertension and blood pressure in early adulthood (ages 30-40 years) with late-life brain health.

Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.